Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Sales: 2016-2025

Historic Return on Sales for Tg Therapeutics (TGTX) over the last 6 years, with Sep 2025 value amounting to 0.84%.

  • Tg Therapeutics' Return on Sales rose 90.00% to 0.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84%, marking a year-over-year increase of 90.00%. This contributed to the annual value of 0.07% for FY2024, which is 2.00% up from last year.
  • According to the latest figures from Q3 2025, Tg Therapeutics' Return on Sales is 0.84%, which was up 531.88% from 0.13% recorded in Q2 2025.
  • Tg Therapeutics' 5-year Return on Sales high stood at 0.84% for Q3 2025, and its period low was -352.35% during Q1 2021.
  • Moreover, its 3-year median value for Return on Sales was 0.07% (2024), whereas its average is -2.76%.
  • Over the last 5 years, Tg Therapeutics' Return on Sales had its largest YoY gain of 31,078bps in 2022, and its largest YoY loss of 2,969bps in 2022.
  • Over the past 5 years, Tg Therapeutics' Return on Sales (Quarterly) stood at -52.39% in 2021, then slumped by 2,969bps to -82.08% in 2022, then skyrocketed by 8,213bps to 0.05% in 2023, then grew by 2bps to 0.07% in 2024, then skyrocketed by 90bps to 0.84% in 2025.
  • Its Return on Sales stands at 0.84% for Q3 2025, versus 0.13% for Q2 2025 and 0.10% for Q1 2025.